Ownership and insider activity for Envista Holdings Corp (NVST): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures.
Price
| Price | $23.94 (closing price, October 28, 2026) |
| Market Cap | $3.8B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-25 | Acurio Veronica | F-InKind | 7,710 | $212K |
| 2026-08-25 | Befidi Robert | F-InKind | 5,147 | $141K |
| 2026-08-25 | Hammes Eric D. | F-InKind | 10,885 | $299K |
| 2026-08-25 | Nilsson Stefan | F-InKind | 804 | $22K |
| 2026-08-20 | Reis Mischa | S-Sale | 8,000 | $220K |
| 2026-08-18 | Keel Paul A | A-Award | 179,730 | |
| 2026-08-18 | Keel Paul A | A-Award | 159,900 | |
| 2026-08-18 | Hammes Eric D. | A-Award | 47,970 | |
| 2026-08-06 | Thomas Coree K. | |||
| 2026-08-06 | Thomas Coree K. |
Balance Sheet (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0 | 0 | $211.2M | $888.9M | $1.07B | $606.9M | $940.0M | $1.07B | $1.21B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $463.1M | $459.8M | $443.6M | $301.7M | $331.9M | $393.5M | $407.5M | $363.0M | $429.6M |
| Inventory | $275.7M | $278.7M | $277.9M | $216.0M | $263.8M | $300.8M | $258.8M | $241.0M | $288.1M |
| Total Current Assets | $794.5M | $786.8M | $1.00B | $1.59B | $1.84B | $1.42B | $1.74B | $1.79B | $2.03B |
| Property, Plant & Equipment | $231.2M | $261.6M | $490.4M | $437.3M | $392.2M | $425.4M | $434.7M | $419.8M | $438.9M |
| Goodwill | $3.37B | $3.33B | $3.31B | $3.21B | $3.13B | $3.50B | $3.29B | $2.26B | $2.36B |
| Intangible Assets | $1.52B | $1.39B | $1.29B | $1.15B | $1.05B | $1.09B | $954.0M | $649.9M | $627.2M |
| Total Assets | $5.99B | $5.84B | $6.16B | $6.88B | $6.57B | $6.59B | $6.61B | $5.35B | $5.68B |
| Accounts Payable | $222.4M | $217.4M | $208.0M | $202.5M | $185.8M | $228.3M | $179.5M | $174.6M | $191.6M |
| Short-term Debt | 0 | 0 | $3.9M | $886.8M | $456.1M | $510.0M | $115.3M | $116.0M | 0 |
| Total Current Liabilities | $628.2M | $641.0M | $709.2M | $1.68B | $1.21B | $1.24B | $780.8M | $878.7M | $852.6M |
| Long-term Debt | 0 | 0 | $1.32B | $907.7M | $883.4M | $870.7M | $1.40B | $1.28B | $1.45B |
| Total Liabilities | $998.2M | $1.02B | $2.62B | $3.15B | $2.52B | $2.38B | $2.43B | $2.42B | $2.57B |
| Retained Earnings | 0 | 0 | $93.1M | $126.4M | $466.9M | $731.4M | $631.2M | -$487.4M | -$440.4M |
| Total Equity | $4.99B | $4.82B | $3.54B | $3.72B | $4.06B | $4.21B | $4.17B | $2.93B | $3.11B |
| Total Debt | 0 | 0 | $1.54B | $1.98B | $1.48B | $1.53B | $1.65B | $1.55B | $1.60B |
| Net Debt | 0 | 0 | $1.33B | $1.09B | $410.0M | $922.2M | $713.6M | $478.6M | $386.0M |
| Working Capital | $166.3M | $145.8M | $292.7M | -$94.1M | $628.0M | $187.9M | $962.9M | $909.6M | $1.17B |
Financial Health
| Debt / Equity | 0.52 |
| Current Ratio | 2.43 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 1.60 |
Profitability
| Return on Equity | 3.08% |
| Return on Invested Capital | 2.38% |
| Return on Assets | 1.70% |
| Gross Margin | 55.50% |
| Operating Margin | 9.92% |
| Net Margin | 3.33% |
Related companies: ICUI · DYN · SUPN · PRVA · GRAL · CON
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of NVST: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks